Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8679500
APP PUB NO 20120121598A1
SERIAL NO

13320097

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions containing antibodies for treating CD5+ HLA-DR+ B OR T cell related diseases such as B or T cell malignances (leukaemia and lymphoma), autoimmune diseases and T cell related diseases as transplantation and graft rejection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS F-75016
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)75013 PARIS
UNIVERSITE DE BRETAGNE OCCIDENTALEBREST

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berthou, Christian Brest Cedex, FR 4 5
Boumsell, Laurence Paris, FR 16 185
Cerruti, Martine Saint Christol les Ales, FR 1 3
Lester, Karine Brest Cedex, FR 2 4
Loisel, Severine Brest Cedex, FR 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 25, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00